Palvella Therapeutics (PVLA) Q2 2025 Earnings

15MayConfirmed
Q4 2024
Q2 2025
-4
-2.91
-1.83
-0.74

Details

Expected EPS
-1.21125
Actual EPS
-0.74
Surprise EPS
0.47
Surprise Percent
+38.91%

Description

Palvella Therapeutics (PVLA) has reported earnings of -0.74 per share for Q2 2025.

0 Comments

Share your thoughts